愛德華生命科學EW
紐約證券 · USD
78.63
-0.68
(-0.86%)
盤中 08/01 10:31 (UTC+8)
08/01 10:31 (UTC+8)
愛德華生命科學EW
78.63
-0.68
(-0.86%)
財務數據
損益表
- 13.48
- 14.60
- 15.30
- 19.38
- 22.61
- 15.98
- 14.03
- 13.21
- 13.86
- 14.13
- 2.22
- 8.25
- 4.84
- 26.62
- 16.71
- -29.32
- -12.22
- -5.85
- 4.91
- 1.94
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 1,412,700 | 1,385,800 | 1,320,900 | 1,402,900 | 1,598,200 | 2,261,200 | 1,937,500 | 1,530,200 | 1,459,600 | 1,348,300 |
營業成本 | 301,600 | 292,200 | 243,700 | 294,700 | 385,600 | 652,400 | 527,000 | 343,000 | 329,500 | 257,900 |
營業毛利 | 1,111,100 | 1,093,600 | 1,077,200 | 1,108,200 | 1,212,600 | 1,608,800 | 1,410,500 | 1,187,200 | 1,130,100 | 1,090,400 |
營業費用 | - | - | - | - | - | 1,036,800 | 877,700 | 860,000 | 741,700 | 642,600 |
研發費用 | 254,600 | 271,100 | 251,500 | 273,700 | 285,200 | 351,000 | 323,300 | 270,300 | 261,200 | 232,200 |
推銷及管理費用 | 450,800 | 469,200 | 436,100 | 455,200 | 531,000 | 675,900 | 552,200 | 441,800 | 437,000 | 405,400 |
非經常性項目費用 | 10,900 | 40,700 | 43,700 | 8,100 | 8,900 | 9,900 | 2,200 | 147,900 | 43,500 | 5,000 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 394,800 | 312,600 | 345,900 | 371,200 | 387,500 | 572,000 | 532,800 | 327,200 | 388,400 | 447,800 |
其他收入及費用 | 39,100 | 97,300 | 52,200 | 17,500 | 21,900 | 38,500 | 21,000 | 11,300 | 10,200 | 30,700 |
利息費用 | - | 19,800 | - | - | - | 17,600 | - | - | - | 19,200 |
稅前純益 | 433,900 | 390,100 | 398,100 | 388,700 | 409,400 | 592,900 | 553,800 | 338,500 | 398,600 | 459,300 |
所得稅 | 70,300 | 45,100 | 40,200 | 20,500 | 58,400 | 80,400 | 80,500 | 33,000 | 58,100 | 60,900 |
稅後純益 | 358,000 | 385,600 | 3,070,800 | 366,300 | 351,900 | 369,900 | 384,900 | 307,100 | 340,500 | 398,400 |
基本每股稅後盈餘(元) | 0.61 | 0.65 | 5.14 | 0.61 | 0.58 | 0.61 | 0.63 | 0.51 | 0.56 | 0.65 |
稀釋每股稅後盈餘(元) | 0.61 | 0.68 | 5.10 | 0.61 | 0.58 | 0.61 | 0.63 | 0.50 | 0.56 | 0.65 |
基本平均股數(千股) | 586900.00 | 589800.00 | 597200.00 | 602100.00 | 601600.00 | 605200.00 | 607000.00 | 606900.00 | 607500.00 | 612900.00 |
稀釋平均股數(千股) | 587800.00 | 590500.00 | 598100.00 | 604300.00 | 604100.00 | 606900.00 | 609500.00 | 610300.00 | 610900.00 | 616200.00 |
還原基本每股稅後盈餘(元) | 0.61 | 0.65 | 5.14 | 0.61 | 0.58 | 0.61 | 0.63 | 0.51 | 0.56 | 0.65 |
還原稀釋每股稅後盈餘(元) | 0.61 | 0.68 | 5.10 | 0.61 | 0.58 | 0.61 | 0.63 | 0.50 | 0.56 | 0.65 |
還原基本平均股數(千股) | 586,900 | 589,800 | 597,200 | 602,100 | 601,600 | 605,200 | 607,000 | 606,900 | 607,500 | 612,900 |
還原稀釋平均股數(千股) | 587,800 | 590,500 | 598,100 | 604,300 | 604,100 | 606,900 | 609,500 | 610,300 | 610,900 | 616,200 |
EBITDA(千元) | 464,900 | 493,100 | 3,145,500 | 426,400 | 448,800 | 504,600 | 502,300 | 376,200 | 433,800 | 513,900 |